Drorit Luria
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Neurology top 5%
- Neuroblastoma Research and Treatments
- Parkinson's Disease Mechanisms and Treatments
Papers in
-
- Acute Lymphoblastic Leukemia research 11
- Hematology 11
- Acute Myeloid Leukemia Research 6
- Hematopoietic Stem Cell Transplantation 4
- Co-authors
- Smadar Avigad (17 shared papers)Rina Zaizov (19 shared papers)Isaac Yaniv (15 shared papers)Anat Achiron (1 shared paper)Ilan Ziv (1 shared paper)Daniel Offen (1 shared paper)Ari Barzilai (1 shared paper)Eldad Melamed (1 shared paper)
In The Last Decade
Drorit Luria
39 papers receiving 971 citations
Peers
Comparison fields: 5 of 81
- Hematology 240
- Neurology 209
- Genetics 91
- Cancer Research 122
- Public Health, Environmental and Occupational Health 199
Countries citing papers authored by Drorit Luria
This map shows the geographic impact of Drorit Luria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Drorit Luria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Drorit Luria more than expected).
Fields of papers citing papers by Drorit Luria
This network shows the impact of papers produced by Drorit Luria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Drorit Luria. The network helps show where Drorit Luria may publish in the future.
Co-authors
The 25 scholars most cited alongside Drorit Luria, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 203 | |
| 2 | 2017 | 86 | |
| 3 | 2005 | 68 | |
| 4 | 2006 | 67 | |
| 5 | 1996 | 54 | |
| 6 | 1995 | 44 | |
| 7 | 2013 | 38 | |
| 8 | 2001 | 37 | |
| 9 | Long-term proliferation of human leukemia cells induced by mouse stroma. | 1989 | 32 |
| 10 | 2015 | 31 | |
| 11 | 2010 | 26 | |
| 12 | 2009 | 26 | |
| 13 | 2004 | 26 | |
| 14 | 2011 | 25 | |
| 15 | 1999 | 25 | |
| 16 | 2009 | 24 | |
| 17 | 2008 | 24 | |
| 18 | 1997 | 22 | |
| 19 | Combined antiproliferative activity of imatinib mesylate (STI-571) with radiation or cisplatin in vitro. | 2007 | 18 |
| 20 | 1997 | 17 |
About Drorit Luria
Drorit Luria is a scholar working on Public Health, Environmental and Occupational Health, Hematology, Neurology, Oncology and Cancer Research, having authored 40 papers that have together received 1.0k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (11 papers), Neuroblastoma Research and Treatments (8 papers), Acute Myeloid Leukemia Research (6 papers), Sarcoma Diagnosis and Treatment (4 papers), Hematopoietic Stem Cell Transplantation (4 papers), Telomeres, Telomerase, and Senescence (3 papers), Neuroendocrine Tumor Research Advances (3 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Hematology (240 citations), Neurology (209 citations), Genetics (91 citations), Cancer Research (122 citations) and Public Health, Environmental and Occupational Health (199 citations). Drorit Luria has collaborated with scholars based in Israel, Czechia and Germany. Frequent co-authors include Smadar Avigad, Rina Zaizov, Isaac Yaniv, Anat Achiron, Ilan Ziv, Daniel Offen, Ari Barzilai, Eldad Melamed, Batia Stark and Shifra Ash. Their work appears in journals such as Cytometry Part B Clinical Cytometry, Blood, Leukemia Research, Cancer and Journal of Pediatric Hematology/Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.